Newsfeeds - Spark Newswire

4 minute read

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Today, 2:47 AM

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

ADMP

2 minute read

Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

Today, 2:47 AM

Gainers ObsEva SA (NASDAQ: OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

1 minute read

Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection

By Vandana Singh

Today, 2:47 AM

Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain.

CDTX

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 2:47 AM

Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 115.1% to $3.42 during Tuesday’s regular session. Trading volume for this…

ARDS

3 minute read

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 2:47 AM

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.

AKAN

5 minute read

Biogen’s 2nd Alzheimer’s Antibody, BeiGene’s Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors

By Shanthi Rexaline

Today, 2:47 AM

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

BGNE

1 minute read

News

Cidara Therapeutics Granted U.S. Patent #11524980: Synthesis of echinocandin antifungal agent

By Charles Gross

Today, 2:47 AM

https://www.scribd.com/document/614190266/CDTX-Patent

CDTX

1 minute read

News

Cidara Therapeutics Granted U.S. Patent #11510992: Compositions and methods for the treatment of viral infections

By Charles Gross

Today, 2:47 AM

https://www.scribd.com/document/611131671/CDTX-Patent

CDTX

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 2:47 AM

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.

ATNX

1 minute read

Cidara’s Lead Antifungal Candidate Goes Under Priority FDA Review

By Vandana Singh

Today, 2:47 AM

The FDA accepted Cidara Therapeutics Inc’s (NASDAQ:CDTX) marketing application seeking approval for rezafungin for candidemia and invasive candidiasis. Under the priority…

CDTX